Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39


Content Validity of a Willingness to Quit Tool for Use with Current Smokers in Clinical Practice.

Baker CL, Bruno M, Grant L, Johnson C, Bennett B, Brohan E, Emir B.

Adv Ther. 2017 Oct;34(10):2295-2306. doi: 10.1007/s12325-017-0611-y. Epub 2017 Sep 22.


HaemoPREF: Further evaluation of patient perception and preference for treatment in a real world setting.

Bonanad S, Schulz M, Gordo A, Spurden D, Cicchetti M, Cappelleri JC, Tolley C, Staunton H, Brohan E.

Haemophilia. 2017 Nov;23(6):884-893. doi: 10.1111/hae.13321. Epub 2017 Sep 19.


Influence of Chirality of Lactones on the Perception of Some Typical Fruity Notes through Perceptual Interaction Phenomena in Bordeaux Dessert Wines.

Stamatopoulos P, Brohan E, Prevost C, Siebert TE, Herderich M, Darriet P.

J Agric Food Chem. 2016 Nov 2;64(43):8160-8167. Epub 2016 Oct 21.


Total Synthesis of Putative 11-epi-Lyngbouilloside Aglycon.

Kolleth A, Gebauer J, ElMarrouni A, Lebeuf R, Prévost C, Brohan E, Arseniyadis S, Cossy J.

Front Chem. 2016 Aug 9;4:34. doi: 10.3389/fchem.2016.00034. eCollection 2016.


Discrimination in the workplace, reported by people with major depressive disorder: a cross-sectional study in 35 countries.

Brouwers EP, Mathijssen J, Van Bortel T, Knifton L, Wahlbeck K, Van Audenhove C, Kadri N, Chang Ch, Goud BR, Ballester D, Tófoli LF, Bello R, Jorge-Monteiro MF, Zäske H, Milaćić I, Uçok A, Bonetto C, Lasalvia A, Thornicroft G, Van Weeghel J; ASPEN/INDIGO Study Group*.

BMJ Open. 2016 Feb 23;6(2):e009961. doi: 10.1136/bmjopen-2015-009961.


Cross-national variations in reported discrimination among people treated for major depression worldwide: the ASPEN/INDIGO international study.

Lasalvia A, Van Bortel T, Bonetto C, Jayaram G, van Weeghel J, Zoppei S, Knifton L, Quinn N, Wahlbeck K, Cristofalo D, Lanfredi M, Sartorius N, Thornicroft G; ASPEN/INDIGO Study Group.

Br J Psychiatry. 2015 Dec;207(6):507-14. doi: 10.1192/bjp.bp.114.156992. Epub 2015 Sep 17.


Development of a Patient-Led End of Study Questionnaire to Evaluate the Experience of Clinical Trial Participation.

Brohan E, Bonner N, Turnbull A, Khan S, Dewit O, Thomas G, Manson S.

Value Health. 2014 Nov;17(7):A649. doi: 10.1016/j.jval.2014.08.2358. Epub 2014 Oct 26. No abstract available.


Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study.

Lanfredi M, Zoppei S, Ferrari C, Bonetto C, Van Bortel T, Thornicroft G, Knifton L, Quinn N, Rossi G, Lasalvia A; ASPEN Study group.

Eur Psychiatry. 2015 Jan;30(1):58-64. doi: 10.1016/j.eurpsy.2014.06.002. Epub 2014 Aug 29.


How much does mental health discrimination cost: valuing experienced discrimination in relation to healthcare care costs and community participation.

Evans-Lacko S, Clement S, Corker E, Brohan E, Dockery L, Farrelly S, Hamilton S, Pinfold V, Rose D, Henderson C, Thornicroft G, McCrone P.

Epidemiol Psychiatr Sci. 2015 Oct;24(5):423-34. doi: 10.1017/S2045796014000377. Epub 2014 Jun 6.


Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study.

Farrelly S, Clement S, Gabbidon J, Jeffery D, Dockery L, Lassman F, Brohan E, Henderson RC, Williams P, Howard LM, Thornicroft G; MIRIAD study group.

BMC Psychiatry. 2014 May 29;14:157. doi: 10.1186/1471-244X-14-157.


Development and psychometric evaluation of a novel tool for assessing patient perception and preference for haemophilia treatment (HaemoPREF).

Teal S, Brohan E, Hettema Y, Humphrey L, Willgoss T, Hudgens S, Westfeld M, Cappelleri JC.

Haemophilia. 2014 Sep;20(5):666-73. doi: 10.1111/hae.12432. Epub 2014 Apr 11.


Stigma and disclosing one's mental illness to family and friends.

Rüsch N, Brohan E, Gabbidon J, Thornicroft G, Clement S.

Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1157-60. doi: 10.1007/s00127-014-0871-7. Epub 2014 Apr 6.


Social capital and reported discrimination among people with depression in 15 European countries.

Zoppei S, Lasalvia A, Bonetto C, Van Bortel T, Nyqvist F, Webber M, Aromaa E, Van Weeghel J, Lanfredi M, Harangozó J, Wahlbeck K, Thornicroft G; ASPEN Study Group.

Soc Psychiatry Psychiatr Epidemiol. 2014 Oct;49(10):1589-98. doi: 10.1007/s00127-014-0856-6. Epub 2014 Mar 18.


Development and preliminary evaluation of a decision aid for disclosure of mental illness to employers.

Brohan E, Henderson C, Slade M, Thornicroft G.

Patient Educ Couns. 2014 Feb;94(2):238-42. doi: 10.1016/j.pec.2013.10.008. Epub 2013 Nov 5.


The development and validation of the Questionnaire on Anticipated Discrimination (QUAD).

Gabbidon J, Brohan E, Clement S, Henderson RC, Thornicroft G; MIRIAD Study Group.

BMC Psychiatry. 2013 Nov 7;13:297. doi: 10.1186/1471-244X-13-297.


Decision aid on disclosure of mental health status to an employer: feasibility and outcomes of a randomised controlled trial.

Henderson C, Brohan E, Clement S, Williams P, Lassman F, Schauman O, Dockery L, Farrelly S, Murray J, Murphy C, Slade M, Thornicroft G.

Br J Psychiatry. 2013 Nov;203(5):350-7. doi: 10.1192/bjp.bp.113.128470. Epub 2013 Sep 26.


Disclosure of a mental health problem in the employment context: qualitative study of beliefs and experiences.

Brohan E, Evans-Lacko S, Henderson C, Murray J, Slade M, Thornicroft G.

Epidemiol Psychiatr Sci. 2014 Sep;23(3):289-300. doi: 10.1017/S2045796013000310. Epub 2013 Aug 6.


Stigma and discrimination against people with schizophrenia related to medical services.

Harangozo J, Reneses B, Brohan E, Sebes J, Csukly G, López-Ibor JJ, Sartorius N, Rose D, Thornicroft G.

Int J Soc Psychiatry. 2014 Jun;60(4):359-66. doi: 10.1177/0020764013490263. Epub 2013 Jun 19.


Development and psychometric evaluation of the Discrimination and Stigma Scale (DISC).

Brohan E, Clement S, Rose D, Sartorius N, Slade M, Thornicroft G.

Psychiatry Res. 2013 Jun 30;208(1):33-40. doi: 10.1016/j.psychres.2013.03.007. Epub 2013 Apr 9.


Supplemental Content

Loading ...
Support Center